Arcutis Biotherapeutics, Inc. ARQT Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s accounts payable?
- Arcutis Biotherapeutics, Inc. (ARQT) reported accounts payable of $18.3M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s accounts payable changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s accounts payable decreased by 25.4% year-over-year, from $24.53M to $18.3M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s accounts payable?
- Over 4 years (2021 to 2025), Arcutis Biotherapeutics, Inc.'s accounts payable has grown at a 33.9% compound annual growth rate (CAGR), from $18.05M to $57.93M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.